期刊
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
卷 34, 期 1, 页码 644-650出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2019.1571273
关键词
Carbonic anhydrase; bacterial/fungal/diatom/protozoan enzymes; Helicobacter pylori; Vibrio cholerae; Burkholderia pseudomallei; Plasmodium falciparum
资金
- Romanian Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III [PN-III-P4-ID-PCCF-2016-0050]
Famotidine, an antiulcer drug belonging to the H-2 antagonists class of pharmacological agents, was recently shown to potently inhibit human (h) and bacterial carbonic anhydrases (CAs, EC 4.2.1.1). We investigated the inhibitory effects of famotidine against all classes of CAs from the pathogenic bacteria Vibrio cholerae, Burkholderia pseudomallei and Mycobacterium tuberculosis Rv3273 beta-CA, as well as the CAs from the nonpathogenic bacteria/cyanobacteria Sulfurihydrogenibium yellowstonensis, S. azorense, Pseudoalteromonas haloplanktis, Colwellia psychrerythraea and Nostoc commune. The delta- and zeta-CAs from the diatom Thalassiosira weissflogii, the fungal enzymes from Cryptococcus neoformans, Candida glabrata and Malassezia globosa, as well as the protozoan enzymes from Trypanosoma cruzi and Plasmodium falciparum, were also investigated. Anopheles gambiae beta-CA was also investigated. All these enzymes were effectively inhibited by famotidine, with affinities between the low nanomolar to the micromolar range. The best inhibition was observed against C. glabrata beta-CA and TweCA zeta, with K(I)s ranging between 13.6 and 22.1 nM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据